| Authors: |
Matte JC; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, CB10 1RQ, UK., Bakker OB; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, CB10 1RQ, UK., Ohl MA; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, CB10 1RQ, UK., Cisternino F; Human Technopole, Viale Rita Levi-Montalcini 1, 20157, Milan, Italy., Manrique-Rincón AJ; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, CB10 1RQ, UK., Husmann A; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, CB10 1RQ, UK., Lichou F; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, CB10 1RQ, UK., Li T; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, CB10 1RQ, UK., Kwakwa K; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, CB10 1RQ, UK., Speak AO; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, CB10 1RQ, UK.; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, UK., Glastonbury CA; Human Technopole, Viale Rita Levi-Montalcini 1, 20157, Milan, Italy., Bayraktar O; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, CB10 1RQ, UK., Jones CP; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, CB10 1RQ, UK., Claussnitzer M; Broad Institute, 75 Ames Street, Broad Institute of MIT and Harvard, 02142 Cambridge US.; The Novo Nordisk Foundation Center for Genomic Mechanisms of Disease, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Genomic Medicine, Massachusetts General Hospital, Center for Genomic Medicine, 185 Cambridge St, Boston, MA 02114 USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Trynka G; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, CB10 1RQ, UK.; Open Targets, Wellcome Genome Campus, Hinxton, CB10 1RQ, UK. |
